Shares of Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) gapped up prior to trading on Tuesday. The stock had previously closed at $3.27, but opened at $3.43. Anbio Biotechnology shares last traded at $3.8530, with a volume of 90,792 shares changing hands.
Analysts Set New Price Targets
Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, October 8th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, Anbio Biotechnology presently has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on NNNN
Anbio Biotechnology Stock Up 18.3%
The stock has a fifty day moving average price of $6.36 and a 200-day moving average price of $15.42.
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
See Also
- Five stocks we like better than Anbio Biotechnology
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
- Adults Are Fueling a Toy Boom—These 4 Stocks Could Cash In
- Could Quantinuum’s Breakthrough Make Its Sell-Off a Bargain?
- Wired for Upside: Why Goldman Sachs Upgraded CoreWeave’s Battered Stock
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
